Literature DB >> 16768751

Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey.

Doron Merkler1, Robert Böscke, Barthel Schmelting, Boldizsár Czéh, Eberhard Fuchs, Wolfgang Brück, Christine Stadelmann.   

Abstract

Recent studies revealed an important involvement of the cerebral cortex in multiple sclerosis (MS) patients. Cortical lesions in MS were reported to be less inflammatory and to show less structural damage than white matter lesions. Animal models reflecting the histopathological hallmarks of cortical demyelinated lesions in MS are sparse. Induction of experimental autoimmune encephalomyelitis (EAE) in the common marmoset has turned out to be an attractive non-human-primate model for MS. In the present study we investigated the presence and detailed cellular composition of cortical inflammatory demyelinating pathology in the common marmoset upon immunization with myelin oligodendrocyte glycoprotein (MOG). Extensive cortical demyelination reflecting the topographically distinct cortical lesion types in MS patients was revealed by immunohistochemistry for myelin basic protein (MBP). We explored the density of T- and B-lymphocytes, MHC-II expressing macrophages/microglia cells and early activated macrophages (MRP14) at perivascular and parenchymal lesions sites in neocortex and subcortical white matter. Despite a similar density of perivascular inflammatory infiltrates in the demyelinated neocortex, a considerable lower fraction of macrophages was found to express MRP14 in the neocortex indicating a different activation pattern in cortical compared with white matter lesions. Furthermore, cortical EAE lesions in marmoset monkeys revealed immunoglobulin leakage and complement component C9 deposition in intracortical but not subpial demyelination. Our findings indicate that the inflammatory response, especially macrophage and microglia activation, may be regulated differently in gray matter areas in primate brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16768751     DOI: 10.1111/j.1750-3639.2006.00004.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  15 in total

Review 1.  Gray matter pathology and multiple sclerosis.

Authors:  Christiane Wegner; Christine Stadelmann
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

2.  Models of autoimmune demyelination in the central nervous system: on the way to translational medicine.

Authors:  Ralf A Linker; De-Hyung Lee
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

3.  The formation of inflammatory demyelinated lesions in cerebral white matter.

Authors:  Pietro Maggi; Sheila M Cummings Macri; María I Gaitán; Emily Leibovitch; Jillian E Wholer; Heather L Knight; Mary Ellis; Tianxia Wu; Afonso C Silva; Luca Massacesi; Steven Jacobson; Susan Westmoreland; Daniel S Reich
Journal:  Ann Neurol       Date:  2014-08-21       Impact factor: 10.422

Review 4.  Advanced MRI and staging of multiple sclerosis lesions.

Authors:  Martina Absinta; Pascal Sati; Daniel S Reich
Journal:  Nat Rev Neurol       Date:  2016-04-29       Impact factor: 42.937

5.  Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis.

Authors:  John W Chen; Michael O Breckwoldt; Elena Aikawa; Gloria Chiang; Ralph Weissleder
Journal:  Brain       Date:  2008-01-29       Impact factor: 13.501

Review 6.  Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development.

Authors:  Yolanda S Kap; Jon D Laman; Bert A 't Hart
Journal:  J Neuroimmune Pharmacol       Date:  2009-10-14       Impact factor: 4.147

7.  Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice.

Authors:  J F Yang; H Q Tao; Y M Liu; X X Zhan; Y Liu; X Y Wang; J H Wang; L L Mu; L L Yang; Z M Gao; Q F Kong; G Y Wang; J H Han; B Sun; H L Li
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

8.  The different clinical effects of anti-BLyS, anti-APRIL and anti-CD20 antibodies point at a critical pathogenic role of γ-herpesvirus infected B cells in the marmoset EAE model.

Authors:  S Anwar Jagessar; Zahra Fagrouch; Nicole Heijmans; Jan Bauer; Jon D Laman; Luke Oh; Thi Migone; Ernst J Verschoor; Bert A 't Hart
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-19       Impact factor: 4.147

9.  An animal model of cortical and callosal pathology in multiple sclerosis.

Authors:  Mario Mangiardi; Daniel K Crawford; Xiaoyu Xia; Sienmi Du; Rebecca Simon-Freeman; Rhonda R Voskuhl; Seema K Tiwari-Woodruff
Journal:  Brain Pathol       Date:  2010-11-10       Impact factor: 6.508

10.  Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis.

Authors:  I M Pomeroy; E K Jordan; J A Frank; P M Matthews; M M Esiri
Journal:  Mult Scler       Date:  2010-03-01       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.